Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories diagnostic Products — Segment Total Assets ($M) ($M)
Postgres DB segment_values + Form 10-K/10-Q XBRL
Latest, Q2 2026
9,709
Period ended Jun 30, 2026
Change on a year earlier
+18.7%
8,177 in Q2 2025
History
22 quarters
Since Q4 2009
Sources
19
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diagnostic Products — Segment Total Assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 9,709 | +18.7% | Form 10-Q (filed 2026-07-28) ↗ |
| Q1 2026 | Mar 31, 2026 | 9,631 | +22.8% | Form 10-Q (filed 2026-04-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 8,273 | +7.7% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 8,201 | – | Form 10-Q (filed 2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 8,177 | – | Form 10-Q (filed 2025-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 7,840 | – | Form 10-Q (filed 2025-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 7,678 | -1.1% | Form 10-K (filed 2025-02-21) ↗ |
| Q4 2023 | Dec 31, 2023 | 7,767 | -2.7% | Form 10-K (filed 2024-02-16) ↗ |
| Q4 2022 | Dec 31, 2022 | 7,985 | +3.7% | Form 10-K (filed 2023-02-17) ↗ |
| Q4 2021 | Dec 31, 2021 | 7,699 | 0.0% | Form 10-K (filed 2022-02-18) ↗ |
| Q4 2020 | Dec 31, 2020 | 7,696 | +47.0% | Form 10-K (filed 2021-02-19) ↗ |
| Q4 2019 | Dec 31, 2019 | 5,235 | +17.3% | Form 10-K (filed 2020-02-21) ↗ |
| Q4 2018 | Dec 31, 2018 | 4,464 | +5.6% | Form 10-K (filed 2019-02-22) ↗ |
| Q4 2017 | Dec 31, 2017 | 4,226 | +43.5% | Form 10-K (filed 2018-02-16) ↗ |
| Q4 2016 | Dec 31, 2016 | 2,945 | +3.6% | Form 10-K (filed 2017-02-17) ↗ |
| Q4 2015 | Dec 31, 2015 | 2,844 | -4.0% | Form 10-K (filed 2016-02-19) ↗ |
| Q4 2014 | Dec 31, 2014 | 2,964 | -10.5% | Form 10-K (filed 2015-02-27) ↗ |
| Q4 2013 | Dec 31, 2013 | 3,312 | +0.8% | Form 10-K (filed 2014-02-21) ↗ |
| Q4 2012 | Dec 31, 2012 | 3,286 | +2.1% | Form 10-K (filed 2014-02-21) ↗ |
| Q4 2011 | Dec 31, 2011 | 3,218 | -7.0% | Form 10-K (filed 2014-02-21) ↗ |
| Q4 2010 | Dec 31, 2010 | 3,462 | -6.1% | Form 10-K (filed 2012-02-21) ↗ |
| Q4 2009 | Dec 31, 2009 | 3,688 | – | Form 10-K (filed 2012-02-21) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Diagnostic Products — Segment Total Assets ($M) ($M), quarterly Q4 2009–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-seg-assets-dx
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.